[VRTX] YoY Annual Result on 31-Dec-2012 [#FY]

Stock
[VRTX] Vertex Pharmaceuticals Incorporated
Announcement Date
01-Mar-2013
Financial Year
2012
Quarter
31-Dec-2012 [#FY]
Profit Trend
YoY- -461.91%
Quarter Report
VRTX's Result
VRTX's Financial Summary
View:
Show?
Annual Result
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
Revenue 1,032,336 580,415 1,211,975 1,527,042 1,410,626 143,370 102,049 47.03%
PBT -559,581 -734,875 -976,117 -12,381 60,445 -754,626 -642,178 -2.26%
Tax 30,381 6,958 -288,567 38,754 19,266 19,275 19,336 7.81%
NP -558,115 -738,555 -445,028 -107,032 29,574 -754,626 -641,578 -2.29%
Tax Rate - - - - -31.87% - - -
Total Cost 1,590,451 1,318,970 1,657,003 1,634,074 1,381,052 897,996 743,627 13.50%
Ratio Analysis
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
NP Margin -54.06 -127.25 -36.72 -7.01 2.10 -526.35 -628.70 -33.55%
Per Share
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
EPS -2.32 -3.14 -1.98 -0.50 0.14 -3.77 -3.70 -7.48%
EPS Diluted -2.31 -3.14 -1.98 -0.50 0.14 -3.77 -3.70 -7.54%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.